# Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial

> **NCT01458327** · PHASE2 · COMPLETED · sponsor: **Resilient Pharmaceuticals** · enrollment: 3 (actual)

## Conditions studied

- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** Midomafetamine
- **BEHAVIORAL:** Therapy

## Key facts

- **NCT ID:** NCT01458327
- **Lead sponsor:** Resilient Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-15
- **Primary completion:** 2014-06-27
- **Final completion:** 2014-06-27
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458327, "Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01458327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*